Home
About
FAQ
History (4)
Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to Know.
Principal Investigator
Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.
Tranexamic Acid
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.
Day SM, Ma T. Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease. Neurosci Bull. 2019 Oct; 35(5):934-936.
View in:
PubMed
subject areas
Alzheimer Disease
Animals
Glucagon-Like Peptide 1
Humans
authors with profiles
Tao Ma PhD